← Back to Clinical Trials
Recruiting NCT04697966

NCT04697966 Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04697966
Status Recruiting
Phase
Sponsor Mclean Hospital
Condition Rumination
Study Type INTERVENTIONAL
Enrollment 158 participants
Start Date 2021-11-16
Primary Completion 2027-05-31

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Mindfulness (Headspace) AppActive Control Condition ("Recharge" condition delivered in Headspace app)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 158 participants in total. It began in 2021-11-16 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A growing body of research implicates rumination as being a transdiagnostic risk factor involved in the development of depression and anxiety in youth. Critically, mindfulness meditation has shown significant promise in targeting rumination, and ultimately improving depressive and anxiety symptoms. Mindfulness apps offer a convenient and cost-effective means for accessing mindfulness training, while being interactive and engaging for youth. Despite their growing popularity among teens, strikingly little research has been conducted on these apps. Two critical questions have yet to be addressed: (1) what are the underlying neural and cognitive mechanisms that account for the beneficial effects of these apps and (2) for whom is app-based mindfulness well-suited. To address these gaps, adolescents (ages 13-18) will be randomly assigned to an app-delivered mindfulness course vs. a control condition and will complete pre- and post-intervention resting state functional magnetic resonance imaging (fMRI) scans to probe static and dynamic functional connectivity within - and between - brain networks strongly implicated in mindfulness training and rumination. In addition, cognitive tasks will be administered at pre- and post-intervention to assess attentional control abilities putatively enhanced by mindfulness training. Finally, mindfulness skills and changes in rumination will be assessed via smartphone-based ecological momentary assessment (EMA). First, the investigators will test whether changes in (1) brain functional connectivity, (2) attentional control and (3) acquisition and use of mindfulness skills mediate between-group (i.e., app vs. control) differences in the reduction of rumination. Second, the investigators will test whether a machine learning model incorporating baseline clinical, demographic, and psychosocial characteristics can be used to identify which adolescents are predicted to benefit from app-based mindfulness training.

Eligibility Criteria

Inclusion Criteria: * Both genders, all ethnicities (see Section: Inclusion of Women and Minorities) * Ages 13-18 years * Written informed assent/consent from adolescent and parent/guardian * English as a first language or English fluency * Right-handed * Personal iPhone or Android smartphone * CRSQ rumination subscale score * If on psychotropic medication, must be on stable dose for at least 2 months Exclusion Criteria: * History or current diagnosis of any of the following DSM-5 disorders: schizophrenia spectrum or other psychotic disorder, bipolar disorder, substance/alcohol use disorder within the past 12 months or lifetime severe substance/alcohol use disorder. * Systemic medical or neurological illness that could impact fMRI measures of cerebral blood flow * Failure to meet standard exclusion criteria for fMRI scanning (e.g. pregnancy, claustrophobia, cardiac or neural pacemakers, surgically implanted metal devices, cochlear implants, metal objects in the body) * History of seizure disorder, or head trauma with loss of consciousness \> 2 mins * Serious or unstable medical illness (e.g., cardiovascular, hepatic, renal, respiratory, endocrine, neurologic or hematologic disease) * Participants with active suicidal ideation will be immediately referred to appropriate clinical treatment. * Current or past treatment with mindfulness-based psychotherapy (e.g., MBCT, DBT or ACT) * Exposure to in-person or app-based mindfulness/meditation course (at least 300 mins of past practice)

Contact & Investigator

Central Contact

Christian Webb, Phd

✉ cwebb@mclean.harvard.edu

📞 6178554429

Frequently Asked Questions

Who can join the NCT04697966 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Rumination. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04697966 currently recruiting?

Yes, NCT04697966 is actively recruiting participants. Contact the research team at cwebb@mclean.harvard.edu for enrollment information.

Where is the NCT04697966 trial being conducted?

This trial is being conducted at Belmont, United States.

Who is sponsoring the NCT04697966 clinical trial?

NCT04697966 is sponsored by Mclean Hospital. The trial plans to enroll 158 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology